Dermatology

>

Latest News

FDA approves roflumilast cream 0.15% for atopic dermatitis in patients aged 6 years, older | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves roflumilast cream 0.15% for atopic dermatitis in patients aged 6 years and up

July 9th 2024

Details of newly FDA-approved roflumilast cream 0.15% for AD in pediatric patients, plus insight and commentary from Lawrence Eichenfield, MD.

FDA approves ustekinumab-ttwe as biosimilar for pediatric plaque psoriasis, active psoriatic arthritis | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves ustekinumab-ttwe as biosimilar for pediatric plaque psoriasis, active psoriatic arthritis

July 9th 2024

Arcutis awaits FDA decision for roflumilast cream 0.15% to treat AD | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
Arcutis awaits FDA decision for roflumilast cream 0.15% to treat AD

July 9th 2024

Image Credit: © Artur - © Artur - stock.adobe.com.
Weekly review: A dermatology case, puzzler, and more

July 8th 2024

POPSICLE-INDUCED COLD PANNICULITIS (POPSICLE PANNICULITIS)
Girl, 8 months, presents with red, painful cheeks

July 1st 2024

Video Interviews
Podcasts
stock image of a hemangioma

More News

© 2024 MJH Life Sciences

All rights reserved.